	Ebitda		Date
Acadia Pharmaceuticals	USD 35.76M	447K	2025-09
Alnylam Pharmaceuticals	USD 145.22M	236.56M	2025-12
Amgen	USD 5.14B	775M	2025-12
Biogen	USD 573.2M	253.7M	2025-12
BioMarin Pharmaceutical	USD -5.26M	300.71M	2025-09
Cytokinetics	USD -277.18M	169.36M	2025-09
Daiichi Sankyo	JPY 101.6B	22.81B	2025-03
Esperion Therapeutics	USD -27.51M	9.5M	2023-09
Gilead Sciences	USD 4.03B	628M	2025-09
Incyte	USD 414.5M	92.42M	2025-12
Ionis Pharmaceuticals	USD -157.12M	307.36M	2025-09
Ironwood Pharmaceuticals	USD 81.81M	31.71M	2025-09
Karyopharm Therapeutics	USD -26.2M	1.83M	2024-09
Novartis	USD 5.88B	290M	2025-09
Pfizer	USD 6.08B	351M	2025-09
PTC Therapeutics	USD 20.63M	53.74M	2025-09
Puma Biotechnology	USD 729K	11.36M	2024-06
Roche Holding	CHF 12.68B	2.36B	2024-06
Sarepta Therapeutics	USD -168.03M	294.45M	2025-09
TG Therapeutics	USD 32.69M	5M	2025-09
Ultragenyx Pharmaceutical	USD -156.79M	65.44M	2025-09
Vertex Pharmaceuticals	USD 1.44B	100.4M	2025-09
Xencor	USD -51.05M	55.28M	2025-12

PTC Therapeutics - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.